Posted inCardiology Hematology-Oncology news
Leveraging Proteomic Signatures of Clonal Hematopoiesis to Predict Outcomes in HFpEF
This study identifies plasma proteomic signatures linked to clonal hematopoiesis driver mutations and develops a proteomic risk score that independently predicts adverse clinical outcomes in heart failure with preserved ejection fraction (HFpEF).